跳至主要内容
临床试验/NCT03851809
NCT03851809已完成2 期

A Randomized Controlled Trial of Wendan Decoction as a Palliative Treatment for Acute Brain Injury

Taichung Tzu Chi Hospital0 个研究点目标入组 60 人开始时间: 2014年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60
主要终点
Glasgow coma scale

研究概览

简要总结

Efficacy and safety of Traditional Chinese Medicine (Wendan decoction) combined with conventional neurologic intensive care in patients with acute moderated to severe brain injury in early stage - A randomized controlled study.

详细描述

This study adopted a prospective, randomized controlled design. All eligible patients included in the study agreed to participated and signed the informed consent from and the study procedures were approved by the ethical committee of Taichung Tzu Chi general hospital (REC103-26). Patients were recruited from the neurosurgery department of Taichung Tzu Chi general hospital between June 2014 and July 2015. A total of 60 patients were enrolled in this study and randomized into intervention group and control group. All patients of both groups were enrolled within 14 days after episode and a follow-up interview until 6 months from the onset. The intervention group mean regular neuro-intensive care combined TCM and the intervention group mean only neuro-intensive care. But there are 7 patients in intervention group and 12 patients in control group quit out this study

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

no masking design

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • traumatic brain injury or spontaneously intracerebral hemorrhage within 14 days of onset;
  • an initial score of 3-12 points of GCS score;
  • adults between 18 to 80 years old;
  • and signed informed consent form.

排除标准

  • after 14 days of onset;
  • a history of previous TBI or stroke;
  • intracranial aneurysm or arteriovenous malformation ruptured;
  • combination other major organ injury (heart, lung, intra-abdomen organ, pelvic fracture, major vessels);
  • other severe disease such as heart or kidney failure;
  • previous diagnosed cancer; and pregnant women.

研究组 & 干预措施

neurologic intensive care in acute brain injury

Experimental

With the guidance of Taiwan Neurosurgical Society and Taiwan Neurological Society, patients in the control group were given the consistent treatment. (http://www.neurosurgery.org.tw/nsr/tbi/main.htm and http://www.stroke.org.tw/guideline/guideline_1.asp). The intensive treatments were established according to the traumatic brain injury treatment guidelines and spontaneously intracerebral hemorrhage general treatment principles from these two society in Taiwan.

干预措施: Wendan decoction combination in acute brain injury (Drug)

结局指标

主要结局

Glasgow coma scale

时间窗: 1 month

from 3 to 15 , higher value indicate better outcome

Ventilator use

时间窗: 1 month

how many days of ventilator use

ICU stay

时间窗: 1 month

how many days of ICU stay

Disability rating scale

时间窗: 1 month

from 0 to 29 , higher value mean worse outcome

modified Rankin scale

时间窗: 1 month

from 0 to 6 , 0 mean normal and 6 mean dead , higher value indicated worse outcome

mortality

时间窗: 1 month

between 1 month mortality

次要结局

  • Glasgow coma scale(6 month)
  • modified Rankin scale(6 month)
  • Disability rating scale(6 month)
  • Barthel index(6 months)

研究者

发起方
Taichung Tzu Chi Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Borren Huang

Director of Neurosurgery department

Taichung Tzu Chi Hospital

相似试验